24/7 Pet Web Search

Search results

1. Results From The WOW.Com Content Network

2. Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs ...

   www.aol.com/bristol-myers-squibb-witnesses...

   Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...

3. Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?

   www.aol.com/bristol-myers-squibb-good-dividend...

   Bristol Myers Squibb stock tanked in April after management lowered the midpoint of its earnings outlook for 2024 from $7.25 per share to just $0.55 to account for a $12.1 billion IPRD charge ...

4. Is Bristol Myers Squibb Stock a Buy?

   www.aol.com/finance/bristol-myers-squibb-stock...

   June 28, 2024 at 7:34 AM. Bristol Myers Squibb (NYSE: BMY) is a big name in healthcare. And over the years, it has always found ways to grow and expand its business. But this hasn't been a good ...

5. Bristol Myers Squibb - Wikipedia

   en.wikipedia.org/wiki/Bristol_Myers_Squibb

   The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

6. Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb

   www.aol.com/better-high-yield-dividend-stock...

   Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. Bristol Myers Squibb, or BMS for short, is another well-established pharmaceutical company with a strong presence in ...

7. Bristol Myers second-quarter results beat expectations ...

   www.aol.com/news/bristol-myers-second-quarter...

   Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its top ...

8. Bristol Myers sales fall, cuts 2023 forecast as drugs face ...

   www.aol.com/news/bristol-myers-sales-fall-cuts...

   Bristol Myers said it earned $1.75 per share in the quarter, well below analyst expectations of $1.96. It cut its 2023 earnings forecast by 60 cents to a range of $7.35 to $7.65 a share.

9. Why This Bristol-Myers Squibb Stock Analyst Is Turning ...

   www.aol.com/news/why-bristol-myers-squibb-stock...

   Key recent clinical pipeline developments have prompted an analyst at Truist Securities to turn bullish on pharma giant Bristol-Myers Squibb Company (NYSE: BMY). The Bristol-Myers Squibb Analyst ...